Inhibition of PIK3CA with BYL719 can overcome resistance to cetuximab in squamous cell carcinoma of the head and neck (SCCHN) Meeting Abstract
| Authors: | Munster, P.; Elkabets, M.; Gilbert, J.; Razak, A. R. A.; Ahn, M. J.; Yen, C. J.; Lee, S. H.; Wang, H. M.; van Herpen, C.; Lim, W. T.; Demanse, D.; Pal, R. R.; Huang, A.; Sheng, Q.; Lambertini, C.; Peters, M.; Coughlin, C.; Scaltriti, M.; Baselga, J.; Blumenschein, G. |
| Abstract Title: | Inhibition of PIK3CA with BYL719 can overcome resistance to cetuximab in squamous cell carcinoma of the head and neck (SCCHN) |
| Meeting Title: | AACR Special Conference: Targeting the PI3K-mTOR Network in Cancer |
| Journal Title: | Molecular Cancer Therapeutics |
| Volume: | 14 |
| Issue: | 7 Suppl. |
| Meeting Dates: | 2014 Sep 14-17 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 1535-7163 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2015-07-01 |
| Language: | English |
| ACCESSION: | WOS:000358159200038 |
| DOI: | 10.1158/1538-8514.pi3k14-a46 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract A46 -- S -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
